GC-MS PROFILE AND CHEMOPROTECTIVE EFFECT OF Cinnamomum zeylanicum BARK ESSENTIAL OIL AGAINST TRIPLE-NEGATIVE BREAST CANCER CELL LINE MDA-MB-231
DOI:
https://doi.org/10.48165/abr.2025.27.01.51Keywords:
Aroma profile, breast cancer, Cinnamomum zeylanicum, cinnamon, essential oil, TNBCAbstract
Cinnamomum zeylanicum Blume (Lauraceae) bark is one of the most important spices used to enhance the taste and flavour of Indian foods. Besides its use as a spice, C. zeylanicum bark possesses antioxidant, antimicrobial, antifungal, anti-inflammatory, and chemoprotective properties. The present study aimed to characterize the key chemical constituents of C. zeylanicum bark essential oil and to determine its chemoprotective effect against triple-negative breast cancer (TNBC) cells. The chemical composition of C. zeylanicum bark essential oil was determined using gas chromatography–mass spectrometry (GC–MS). The analysis identified 29 chemical compounds, among which (E)-cinnamaldehyde (69.89%), eugenol (14.27%), δ-cadinene (2.80%), and (Z)-caryophyllene (2.33%) were the major constituents. The essential oil exhibited concentration- and time-dependent inhibition of TNBC (MDA-MB-231) cells. A concentration of 15.62 μL mL⁻¹ produced maximum inhibition of MDA-MB-231 cells, amounting to approximately 90.6%. The aroma profile and significant in vitro anticancer activity of C. zeylanicum bark essential oil provide a scientific basis for its potential use as a cancer remedy
Downloads
References
Abd Wahab, W. and Adzmi, A.N. 2017. The investigation of cytotoxic effect of Cinnamomum zeylanicum extracts on human breast cancer cell line (MCF7). Science Heritage Journal, 1(2): 23-28.
Aggarwal, S., Bhadana, K., Singh, B., Rawat, M., Mohammad, T., Al-Keridis, L.A., et al., 2022. Cinnamomum zeylanicum extract and its bioactive component cinnamaldehyde show anti-tumor effects via inhibition of multiple cellular pathways. Frontiers in Pharmacology, 13: 918479. [doi: 10.3389/fphar.2022.918479].
Ahamad, J. 2021. Aroma profile and α-glucosidase inhibitory activity of essential oil of Mentha spicata leaves. Journal of Essential Oil Bearing Plants, 24(5): 1042-1048.
520 Javed Ahamad.
Ahamad, J. 2024. Anticancer potential of cardamom (Elettaria cardamomum) essential oil against TNBC, Glioma and kidney cancer in vitro. Integrative Biomedical Research, 8(9): 1-7. Ahamad, J., Uthirapathy, S., Mohammed Ameen, M.S. and Anwer, E.T. 2019. Essential oil composition and antidiabetic, anticancer activity of Rosmarinus officinalis L. leaves from Erbil (Iraq). Journal of Essential Oil Bearing Plants, 22(6): 1544-1553.
Ahmad, J., Ahamad, J., Algahtani, M.S., Garg, A., Shahzad, N., Ahmad, M.Z., et al., 2024. Nanotechnology-mediated delivery of resveratrol as promising strategy to improve therapeutic efficacy in triple negative breast cancer (TNBC): Progress and promises. Expert Opinion on Drug Delivery, 21(2): 229-244.
Al-fekaiki, D.F., Niamah, A.K. and Al-Sahlany, S.T.G. 2017. Extraction and identification of essential oil from Cinnamomum zeylanicum barks and study the antibacterial activity. The Journal of Microbiology, Biotechnology and Food Sciences, 7(3): 312. [https://doi.org/10.15414/jmbfs. 2017/18.7.7.312-316].
Alizadeh Behbahani, B., Falah, F., Lavi Arab, F., Vasiee, M. and Tabatabaee Yazdi, F. 2020. Chemical composition and antioxidant, antimicrobial, and antiproliferative activities of Cinnamomum zeylanicum bark essential oil. Evidence‐Based Complementary and Alternative Medicine, 2020(1): 5190603. [doi: 10.1155/2020/5190603].
Anand, V., Kumar, S. and Hedina, A. 2016. Cinnamomum zeylanicum Linn. The spice with multi potential. Systematic Reviews in Pharmacy, 7(1): 24-29. [doi: 10.5530/srp.2016.7.3]. Babushok, V.I., Linstrom, P.J. and Zenkevich, I.G. 2011. Retention indices for frequently reported compounds of plant essential oils. Journal of Physical and Chemical Reference Data, 40(4): 043101-47. [doi: 10.1063/1.3653552].
Benedetti, S., Nasoni, M.G., Luchetti, F. and Palma, F. 2023. New insights into the cytotoxic effects of Thymus vulgaris essential oil on the human triple-negative breast cancer cell line MDA-MB 231. Toxicology in Vitro, 93: 105705. [doi: 10.1016/j.tiv.2023.105705].
Cappelli, G., Giovannini, D., Vilardo, L., Basso, A., Iannetti, I., Massa, M. and Mariani, F. 2023. Cinnamomum zeylanicum blume essential oil inhibits metastatic melanoma cell proliferation by triggering an incomplete tumour cell stress response. International Journal of Molecular Sciences, 24(6): 5698. [doi: 10.3390/ijms24065698].
Foulkes, W.D., Smith, I.E. and Reis-Filho, J.S. 2010. Triple-negative breast cancer. New England Journal of Medicine, 363(20): 1938-1948.
Hameed, I.H., Altameme, H.J. and Mohammed, G.J. 2016. Evaluation of antifungal and antibacterial activity and analysis of bioactive phytochemical compounds of Cinnamomum zeylanicum (Cinnamon bark) using gas chromatography-mass spectrometry. Oriental Journal of Chemistry, 32(4): 1769. [http://dx.doi.org/10.13005/ojc/320406].
Husain, I., Ahmad, R., Chandra, A., Raza, S.T., Shukla, Y. and Mahdi, F. 2018. Phytochemical characterization and biological activity evaluation of ethanolic extract of Cinnamomum zeylanicum. Journal of Ethnopharmacology, 219: 110-116.
Jayaprakasha, G.K., Jagan Mohan Rao, L. and Sakariah, K.K. 2003. Volatile constituents from Cinnamomum zeylanicum fruit stalks and their antioxidant activities. Journal of Agricultural and Food Chemistry, 51(15): 4344-4348.
Kazemi, M. and Mokhtariniya, S. 2016. Essential oil composition of bark of Cinnamomum zeylanicum. Journal of Essential Oil Bearing Plants, 19(3): 786-789.
Kubatka, P., Kello, M., Kajo, K., Samec, M., Jasek, K., Vybohova, D. and Mojzis, J. 2020. Chemopreventive and therapeutic efficacy of Cinnamomum zeylanicum L. bark in experimental breast carcinoma: Mechanistic in vivo and in vitro analyses. Molecules, 25(6): 1399. [https://doi.org/10.3390/molecules25061399].
Lauricella, M., Maggio, A., Badalamenti, N., Bruno, M., D'Angelo, G.D. and D'Anneo, A. 2022. Essential oil of Foeniculum vulgare subsp. piperitum fruits exerts an anti-tumor effect in triple negative breast cancer cells. Molecular Medicine Reports, 26(1): 243. [doi: 10.3892/mmr.2022.12759].
GC-MS profile and anticancer activity of cinnamon essential oil against TNBC 521
Najibullah, S.N.M., Ahamad, J., Sultana, S. and Zafar, A. 2022. Chemical characterization and evaluation of anticancer activity of Pistacia terebinthus Linn. fruits essential oil. Journal of Essential Oil Bearing Plants, 25(1): 180-187.
Ranasinghe, P., Pigera, S., Premakumara, G.S., Galappaththy, P., Constantine, G.R. and Katulanda, P. 2013. Medicinal properties of ‘true’cinnamon (Cinnamomum zeylanicum): A systematic review. BMC Complementary and Alternative Medicine, 13(1): 275. [doi: 10.1186/1472-6882- 13-275].
Rao, P.V. and Gan, S.H. 2014. Cinnamon: A multifaceted medicinal plant. Evidence‐Based Complementary and Alternative Medicine, 2014(1): 642942. [doi: 10.1155/2014/642942]. Tran, H.N., Graham, L. and Adukwu, E.C. 2020. In vitro antifungal activity of Cinnamomum zeylanicum bark and leaf essential oils against Candida albicans and Candida auris. Applied Microbiology and Biotechnology, 104(20): 8911-8924.
Unlu, M., Ergene, E., Unlu, G.V., Zeytinoglu, H.S. and Vural, N. 2010. Composition, antimicrobial activity and in vitro cytotoxicity of essential oil from Cinnamomum zeylanicum Blume (Lauraceae). Food and Chemical Toxicology, 48(11): 3274-3280.
Varalakshmi, B., Anand, A.V., Karpagam, T., Bai, J.S. and Manikandan, R. 2014. In vitro antimicrobial and anticancer activity of Cinnamomum zeylanicum Linn. bark extracts. International Journal of Pharmacy and Pharmaceutical Science, 6(1): 12-18.
Zhang, M., Qiu, B., Sun, M., Wang, Y., Wei, M., Gong, Y. and Yan, M. 2022. Preparation of black pepper (Piper nigrum L.) essential oil nanoparticles and its antitumor activity on triple negative breast cancer in vitro. Journal of Food Biochemistry, 46(12): e14406. [doi: 10.1111/jfbc.14406].
Zito, P., Labbozzetta, M., Notarbartolo, M., Sajeva, M. and Poma, P. 2019. Essential oil of Cyphostemma juttae (Vitaceae): Chemical composition and antitumor mechanism in triple negative breast cancer cells. PLOS One, 14(3): e0214594. [https://doi.org/10.1371/ journal.pone. 0214594].
